Cargando…

Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies

Comprehensive Genomic Profiling may be informative for novel treatment strategies and to improve outcomes for patients with rare tumors. This study aims to discover opportunities for use of targeted therapies already approved for routine use in patients with rare tumors. Solid tumors with an inciden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuhang, Chen, Rongrong, Tang, Yu, Yu, Yue, Fang, Yuan, Huang, Huiyao, Wu, Dawei, Fang, Hong, Bai, Ying, Sun, Chao, Yu, Anqi, Fan, Qi, Gu, Dejian, Yi, Xin, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186305/ https://www.ncbi.nlm.nih.gov/pubmed/32373528 http://dx.doi.org/10.3389/fonc.2020.00536

Ejemplares similares

Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy
por: Wang, Shuhang, et al.
Publicado: (2021)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
por: Huang, Huiyao, et al.
Publicado: (2022)

Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours
por: Wang, Shuhang, et al.
Publicado: (2021)

Targeting rare tumors: new focus for clinical research in China
por: Wang, Shuhang, et al.
Publicado: (2022)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

Outcome measures of phase III anticancer drug trials in China
por: Guo, Lanwei, et al.
Publicado: (2023)

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
por: Huang, Huiyao, et al.
Publicado: (2023)

Association between germ-line HLA and immune-related adverse events
por: Jiang, Ning, et al.
Publicado: (2022)

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
por: Wang, Shuhang, et al.
Publicado: (2022)

Seven-year exclusivity and beyond for drugs of rare diseases in China
por: Jiang, Yale, et al.
Publicado: (2023)

Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell Carcinoma
por: Qian, Jie, et al.
Publicado: (2020)

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges
por: Huang, Huiyao, et al.
Publicado: (2022)

All the Routes for Laparoscopic Liver Segment VIII Resection: A Comprehensive Review of Surgical Techniques
por: Anselmo, Alessandro, et al.
Publicado: (2022)

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses
por: Liu, Yu-Qing, et al.
Publicado: (2019)

Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer
por: Yu, Haipeng, et al.
Publicado: (2022)

Urine- and Blood-Based Molecular Profiling of Human Prostate Cancer
por: Chen, Gang, et al.
Publicado: (2022)

Comprehensive Analysis of the Functions and Prognostic Value of RNA-Binding Proteins in Thyroid Cancer
por: Ma, Yue, et al.
Publicado: (2021)

Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma
por: Tao, Ping, et al.
Publicado: (2021)

Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing
por: Li, Hongsen, et al.
Publicado: (2022)

Altered Signaling Pathways Revealed by Comprehensive Genomic Profiling in Patients With Unknown Primary Tumors
por: Yang, Zhen, et al.
Publicado: (2022)

Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy
por: Song, Yu-Chun, et al.
Publicado: (2023)

Comprehensive genomic profiling: Does timing matter?
por: Thapa, Bicky, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Microenvironment-Related Genes in Invasive Breast Cancer
por: Shi, Yingrong, et al.
Publicado: (2022)

Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma
por: Huo, Yansong, et al.
Publicado: (2022)

Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention
por: Dawei, Wu, et al.
Publicado: (2022)

Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma
por: Zhu, Yuanyuan, et al.
Publicado: (2021)

Diagnostic value of magnetic resonance imaging ectopic posterior pituitary hyperintense signal in pituitary macroadenoma
por: Luo, Yi-Lin, et al.
Publicado: (2022)

Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial
por: Song, Yu-Chun, et al.
Publicado: (2021)

Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer
por: Yang, Huaxia, et al.
Publicado: (2021)

Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
por: Wang, Shuhang, et al.
Publicado: (2022)

Comprehensive energy management: eco routing & velocity profiles
por: Watzenig, Daniel, et al.
Publicado: (2017)

Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups
por: Li, Peng, et al.
Publicado: (2022)

Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer
por: Yang, Jinwei, et al.
Publicado: (2023)

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis
por: Tang, Qiyu, et al.
Publicado: (2023)

Comprehensive analysis and molecular map of Hippo signaling pathway in lower grade glioma: the perspective toward immune microenvironment and prognosis
por: Guo, Yu-Duo, et al.
Publicado: (2023)

Development and Validation of a Prognostic Model to Predict Recurrence-Free Survival After Curative Resection for Perihilar Cholangiocarcinoma: A Multicenter Study
por: Liu, Zhi-Peng, et al.
Publicado: (2022)

Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor
por: Wang, Li-Xin, et al.
Publicado: (2023)

Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study
por: Yang, Jingjing, et al.
Publicado: (2022)

Genomic profiling of non-small cell lung cancer with the rare pulmonary lymphangitic carcinomatosis and clinical outcome of the exploratory anlotinib treatment
por: Dong, Changqing, et al.
Publicado: (2022)

A Deep Learning System to Predict the Histopathological Results From Urine Cytopathological Images
por: Liu, Yixiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2kcp53r8p8odd0or7a4e2bv0i9